Jingtao Zhong

2PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 16, 2024
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial.

Zhongchao Li, Jing Liu, Bo Zhang

|Apr 11, 2020
Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.

Yinghong Zhou, Xiaofeng Dong, Peng Xiu

Pageof 1

Frequent Collaborators

2 joint publications

Pengfei Sun

2 joint publications

Xuetao Shi

1 joint publications

Yinghong Zhou

1 joint publications

Xiaofeng Dong